Savant Capital’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-2,338
| Closed | -$278K | – | 1433 |
|
2024
Q2 | $278K | Sell |
2,338
-929
| -28% | -$110K | ﹤0.01% | 1006 |
|
2024
Q1 | $348K | Buy |
3,267
+223
| +7% | +$23.8K | ﹤0.01% | 849 |
|
2023
Q4 | $303K | Sell |
3,044
-290
| -9% | -$28.8K | ﹤0.01% | 700 |
|
2023
Q3 | $344K | Sell |
3,334
-740
| -18% | -$76.4K | 0.01% | 613 |
|
2023
Q2 | $495K | Buy |
4,074
+1,703
| +72% | +$207K | 0.01% | 510 |
|
2023
Q1 | $364K | Buy |
2,371
+258
| +12% | +$39.6K | 0.01% | 545 |
|
2022
Q4 | $380K | Buy |
2,113
+390
| +23% | +$70.1K | 0.01% | 410 |
|
2022
Q3 | $204K | Buy |
+1,723
| New | +$204K | 0.01% | 511 |
|
2022
Q2 | – | Sell |
-1,306
| Closed | -$225K | – | 571 |
|
2022
Q1 | $225K | Buy |
1,306
+132
| +11% | +$22.7K | 0.01% | 521 |
|
2021
Q4 | $298K | Buy |
+1,174
| New | +$298K | 0.01% | 452 |
|